MCK earnings: real EPS beat/miss history, analyst consensus Buy, P/E 21.07. Updated 2026-07-23.
McKesson (MCK) Research Hub
McKesson (MCK) trades on NYSE, US in the Healthcare (Medical - Distribution) sector. As of 2026-09-11, shares last closed at 881.51 USD (-1.14%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.07, market cap 96.25B. This hub links to the full technical, earnings and options research available for MCK.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Distribution) |
|---|---|
| Exchange | NYSE, US |
| Last close | 881.51 USD (-1.14%) |
| 52-week range | 744.45 USD – 929.95 USD |
| Trend regime | Range |
| 14-day RSI | 52.7 (Neutral) |
| Trailing P/E | 21.07 |
| Market cap | 96.25B |
| Dividend yield | 0.40% |
Available research for MCK
Covered Call on MCK: how it works, illustrative setup around the real 881.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MCK: how it works, illustrative setup around the real 881.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MCK: how it works, illustrative setup around the real 881.51 USD price, max profit/loss, breakeven and when to use it. Educational.
MCK technical analysis: range, last 881.51 USD, RSI 52.7, 52w range 744.45 USD–929.95 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MCK in?
McKesson (MCK) is classified under Healthcare (Medical - Distribution), listed on NYSE, US.
Is MCK in an uptrend or downtrend?
As of 2026-09-11, MCK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MCK's trailing P/E ratio?
MCK's trailing P/E is 21.07, with a market cap of 96.25B. See the earnings research page for full valuation detail.